Home » Topics » BioWorld Science

BioWorld Science
RSS

In vivo antitumoral activity seen with mixture of cytokine-encoding mRNAs

May 29, 2019

AiCuris reports agents for the treatment of HBV infections

May 29, 2019

P2X3 and/or P2X2/3 receptor antagonists described in Beijing Tide Pharmaceutical patent

May 29, 2019

Idorsia prepares and tests antibacterial compounds

May 29, 2019

AbbVie and Calico Life Sciences jointly describe EIF2B activators

May 29, 2019

Researchers develop new murine model of dystrophic epidermolysis bullosa-squamous cell carcinoma

May 29, 2019

ProMIS identifies antibody candidates that selectively bind toxic oligomers of tau for Alzheimer's

May 29, 2019

Bristol-Myers Squibb patents farnesoid X receptor agonists

May 29, 2019

Ziopharm and NCI sign T-cell technology licensing agreement

May 29, 2019

Integral Molecular achieves milestone in Daiichi Sankyo immuno-oncology collaboration

May 29, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...